NR 565 Advanced Pharmacology Fundamentals
Midterm and Final Comprehensive Examination
2026/2027 | Verified Questions
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals | University-Level
Advanced Nursing Students
100 Verified Questions | 4 Core Domains | Academic Year 2026/2027
Prepared by
Chamberlain College of Nursing | NR 565 Advanced Pharmacology Fundamentals
Midterm and Final Comprehensive Examination Actual Exam | Academic Year 2026/2027
NR 565 Advanced Pharmacology Fundamentals Midterm and Final Comprehensive Examination 2026/2027 | Verified Questions
,INTRODUCTION
This document contains 100 original verified questions designed for the NR 565 Advanced Pharmacology
Fundamentals Midterm and Final Comprehensive Examination. The questions are organized across four
core domains: Pharmacologic Principles and Pharmacokinetics (25 questions); Cardiovascular and
Respiratory Pharmacology (25 questions); Neurological, Psychiatric, and Pain Management
Pharmacology (25 questions); and Endocrine, Gastrointestinal, and Musculoskeletal Pharmacology (25
questions). Content is original and constructed to reinforce the official Chamberlain College of Nursing
NR 565 course objectives for actual exam readiness and clinical proficiency, aligned to the 2026/2027
academic year. Each question includes a correct answer and a rationale grounded in foundational
advanced pharmacology curriculum and prescribing standards.
ACTUAL QUESTIONS
Domain 1: Pharmacologic Principles and Pharmacokinetics
Question 1. Which pharmacokinetic process describes the movement of a drug from the
site of administration into the bloodstream?
A. Distribution
B. Metabolism
C. Absorption
D. Excretion
Correct Answer: C
Rationale: Absorption is the process by which a drug enters the systemic circulation from its site of
administration. Distribution, metabolism, and excretion follow absorption.
Question 2. What is the primary site of drug metabolism for most oral medications?
A. Kidney
B. Liver
C. Lung
D. Small intestine exclusively
Correct Answer: B
Rationale: The liver contains high concentrations of cytochrome P450 enzymes responsible for Phase I
and Phase II metabolism of the majority of drugs.
Question 3. Which term describes the fraction of an administered drug that reaches the
systemic circulation unchanged?
A. Bioavailability
B. Half-life
C. Clearance
D. Volume of distribution
Correct Answer: A
NR 565 Advanced Pharmacology Fundamentals Midterm and Final Comprehensive Examination 2026/2027 | Verified Questions
,Rationale: Bioavailability is the proportion of the administered dose that reaches the systemic
circulation in unchanged form.
Question 4. A drug with a high volume of distribution (Vd) is most likely to:
A. Remain confined to the plasma compartment
B. Be eliminated solely by renal filtration
C. Distribute extensively into tissues outside the plasma
D. Have negligible tissue binding
Correct Answer: C
Rationale: A large Vd indicates extensive distribution into extravascular tissues, often due to high lipid
solubility or tissue binding.
Question 5. Which cytochrome P450 enzyme is responsible for metabolizing a large
proportion of clinically used drugs, including many antidepressants and opioids?
A. CYP3A4
B. CYP2D6
C. CYP2C9
D. CYP1A2
Correct Answer: A
Rationale: CYP3A4 is the most abundant hepatic CYP enzyme and metabolizes approximately half of all
marketed drugs.
Question 6. What is the clinical significance of a drug having a narrow therapeutic index?
A. The drug can be given in any dose without monitoring
B. Small differences in dose or blood concentration may lead to therapeutic failure or toxicity
C. The drug has no adverse effects
D. The drug is always administered by the intravenous route
Correct Answer: B
Rationale: Narrow therapeutic index drugs require careful dosing and often therapeutic drug
monitoring because the margin between efficacy and toxicity is small.
Question 7. Which process is primarily responsible for the termination of action of most
drugs?
A. Metabolism and excretion
B. Receptor downregulation only
C. Immediate physical removal from the body
D. Binding to plasma proteins exclusively
NR 565 Advanced Pharmacology Fundamentals Midterm and Final Comprehensive Examination 2026/2027 | Verified Questions
, Correct Answer: A
Rationale: Drug action is terminated mainly by metabolic inactivation and/or excretion of the parent
drug or metabolites.
Question 8. First-pass metabolism refers to:
A. The first time a drug is metabolized after chronic use
B. Metabolism that occurs only in the kidney
C. Metabolism of an orally administered drug in the intestine and liver before it reaches the systemic
circulation
D. The initial distribution phase of an IV drug
Correct Answer: C
Rationale: Oral drugs absorbed from the GI tract pass through the portal circulation to the liver, where
a portion may be metabolized before reaching systemic circulation.
Question 9. Which factor most strongly influences the rate of glomerular filtration of a
drug?
A. Only the lipid solubility of the drug
B. Degree of plasma protein binding and molecular size
C. The color of the tablet formulation
D. The time of day the drug is administered
Correct Answer: B
Rationale: Only unbound (free) drug of sufficiently small molecular size is filtered at the glomerulus.
Question 10. What is the primary mechanism of action of a competitive antagonist?
A. Binds to the same receptor site as the agonist and can be overcome by increasing agonist
concentration
B. Irreversibly destroys the receptor
C. Activates the receptor more strongly than the agonist
D. Inhibits drug metabolism
Correct Answer: A
Rationale: Competitive antagonists occupy the orthosteric site, shifting the agonist dose-response curve
to the right in a surmountable manner.
Question 11. Steady-state plasma concentration is reached after approximately how many
half-lives of continuous dosing?
A. One half-life
B. Ten half-lives
C. Immediately after the first dose
NR 565 Advanced Pharmacology Fundamentals Midterm and Final Comprehensive Examination 2026/2027 | Verified Questions